Bamboo

Bamboo: A Comprehensive Reference on Its Identity, Ethnopharmacology, Phytochemistry, and Scientific Evidence

1. Identity and Botanical Classification

Bamboo is not a single species but a diverse subfamily of woody grasses. Bamboo (Phyllostachys edulis J. Houz) is an economically important member of the family Poaceae, subfamily Bambusoideae, with species that adapt to a wide variety of climates. The subfamily encompasses hundreds of species distributed across tropical, subtropical, and temperate regions of Asia, Africa, and the Americas.

The species most commonly employed in dietary supplements and herbal medicine include:

• Bambusa bambos (L.) Voss — the species of primary interest for silica extraction and the source of the Ayurvedic preparation known as Tabashir or Vanshalochan.
• Bambusa arundinacea Willd. — closely related to B. bambos and used as a source of bamboo-derived silica in clinical formulations.
• Bambusa vulgaris Schrad. — widely distributed tropical species used in ethnomedicine and studied for its cyanogenic glycoside chemistry.
• Phyllostachys edulis (Carrière) J.Houz (Moso bamboo) — the species most studied for leaf extract pharmacology, including anti-inflammatory and lipotoxicity-protective effects.
• Phyllostachys pubescens — extensively studied for its phytochemical profile across different plant parts.
• Phyllostachys nigra (Lodd.) Munro (black bamboo) — studied for bioactive leaf compounds including orientin.
• Sasa albomarginata (Kumazasa) and Sasa borealis — Japanese species commercially used as dietary supplements and studied for anti-inflammatory and antidiabetic properties.
• Pseudosasa japonica — studied in the context of anti-obesity and antidiabetic effects in animal models.

Common names and preparation names used across traditions include: bamboo extract, bamboo silica, Zhu Ru (Traditional Chinese Medicine — bamboo shavings), Tabashir/Tabasheer (Ayurvedic — bamboo manna or sap), and bamboo leaf extract.

1.1 Plant Parts Used

Different parts of the bamboo plant contribute distinct pharmacological profiles:

• Leaves: Rich in flavonoids, phenolic acids, and polysaccharides; the principal source of bamboo leaf extract (BLE/BEX) used in most pharmacological studies.
• Shoots: Bamboo shoots, as the young bamboo stems, are rich in protein, fiber, vitamins, and minerals, as well as many bioactive substances beneficial to health, and are gaining in importance worldwide as a healthy food and dietary supplement.
• Culm (stem/trunk): Outer culm and inner culm were found to be the most important sources of active compounds in studies on Phyllostachys pubescens.
• Tabashir (bamboo manna): Tabasheer, distinguished by its silica-rich composition, showcases the botanical excellence of bamboo. This gelatinous substance, found within the hollow stems of certain bamboo species, is esteemed for its medicinal properties in traditional practices across India and China.

1.2 Common Commercial Forms and Preparations

• Standardized stem/leaf extract capsules (typically standardized to 70–75% silica): the most prevalent supplement form for targeted silica delivery.
• Bamboo leaf extract powder: used in encapsulated supplements and as a food additive, standardized for total flavonoid or polyphenol content.
• Bamboo leaf tea: a traditional preparation delivering flavonoids, polyphenols, and moderate silica in an aqueous extract.
• Ethanolic/aqueous extracts (BEX): Made from fresh leaves and small branches of bamboo Phyllostachys edulis in Hunan Province, China, through a patented ethanol/water extraction procedure, used in research settings.
• Fermented bamboo shoot preparations: consumed as foods and traditional medicinal foods in Northeast India, China, Japan, and Southeast Asia.
• Tabashir powder or resin: the dried, silica-rich exudate from bamboo internodes, used directly in Ayurvedic formulations.

---

2. Traditional and Historical Use

2.1 Overview and Antiquity

The plant has superior value in traditional indigenous systems of China, Ayurveda, Siddha, and Unani for its enormous medicinal and nutritional purposes since 2500 years. Biomedical investigations on the health-benefiting effects as well as toxicity of different parts and species of bamboo have been carried out worldwide since the 1960s. The earliest scientific documentation of potential medicinal use of bamboo was published in the early 1960s (Sakai et al., 1963), followed by a series of studies in the 1970s. Bamboo as a biomedical research topic was relatively silent during the 1980s and 1990s, but research interest increased worldwide since the beginning of this century.

2.2 Traditional Chinese Medicine (TCM)

In Traditional Chinese Medicine (TCM), bamboo (Zhu Ru) was used to clear "heat," calm the mind, and strengthen bones and hair. Bamboo leaves have historically been used in TCM for treatment of cough, improvement of eyesight, and for detoxification. Generally, bamboo leaves are used as traditional medicine to treat diseases such as cough, rheumatism, influenza, fever, skin disease, heart disease, and malaria.

2.3 Ayurveda, Siddha, and Unani

Traditional Ayurvedic medicine has used bambusa for many conditions such as cough, skin diseases, wounds, digestive conditions, nausea, hormonal and gynaecological disorders, fever, ringworm, bleeding gums, painful joints, and as an aphrodisiac. The silica-rich concretion found within bamboo internodes — known as Tabashir or Vanshalochan — holds a particularly prominent place. The use of Bamboo manna traces back to ancient times, where it was highly esteemed in traditional healing practices. References to bamboo and its medicinal properties can be found in ancient Ayurvedic texts such as the Charaka Samhita. Historically, Bamboo manna has been utilized in Ayurveda and Traditional Chinese Medicine for treating a variety of ailments. The high silica content in Bamboo manna is particularly beneficial for supporting bone health, enhancing digestive functions, and improving skincare. Additionally, it has been employed to alleviate urinary disorders, respiratory conditions, and to promote balance within the nervous system.

In Ayurvedic classification, bamboo preparations were considered to act as tonic, expectorant, aphrodisiac, and haemostatic agents. Bamboo tabashir (gum) was historically used for cough and bronchitis. Its mucilaginous texture is thought to soothe irritated mucosa, while phenolic compounds exert mild expectorant effects. Bamboo shoot decoctions are used as a carminative and mild laxative. The dietary fiber and mannan content promote satiety and healthy bowel habits, addressing both constipation and dyspepsia in Ayurveda's "kaphaj" digestive imbalances.

2.4 Japanese and Southeast Asian Traditions

Hot water extract of Sasa albomarginata (Kumazasa) leaves is commercially available and used as a dietary supplement or skincare cream in Japan, reflecting the continuation of traditional use into the modern market. There are instances of using bamboo shoots by Karbi Anglong tribes of India to control early stage of cancer. Regular intake of bamboo shoots is reported to reduce reproductive health-related problems in female populations; bamboo shoots are used by local tribes belonging to Bodo, Thadau, Mosang, and Tiwa for treatment of irregular menstrual cycle, heavy bleeding after delivery, infertility problems, reducing labour pain, and also for inducing puberty in young females. These ethnobotanical uses have not been substantiated by clinical trials.

Bamboo has been used as a medicine for centuries in China, India and Tibet. The resin collected from the knots in the stems is called Tabashir. The shaved young shoots and the leaves also have medicinal value.

---

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Complexity

Eighty-two phytochemical studies have been summarized in reviews of bamboo, which are majorly due to the presence of secondary active metabolites such as phenolics, flavonoids, terpenoids, steroid glycosides and coumarins along with minor constituents like polysaccharides, ketones, tannins, lignans. Several phytochemicals, including carotenoids, phenolic compounds (flavonoids, phytoestrogens, phenolic acids), phytosterols and phytostanols, saponins, tocotrienols, organosulfur compounds (allium compounds and glucosinolates), and alkaloids, are present in bamboo shoots and have significant medical and nutraceutical applications.

3.2 Flavonoids and C-Glycosyl Flavones

Flavonoids — particularly C-glycosyl flavones — represent the dominant and most pharmacologically investigated class of compounds in bamboo leaves. The glycoside, di-C,C-hexosylapigenin, is the most common compound found in different parts of bamboo, including leaf, outer culm, inner culm, and root. Additional key flavonoids identified include:

• Isoorientin (8-C-glucosylluteolin) and Orientin (6-C-glucosylluteolin): UHPLC-PDA analysis revealed evidence for the presence of protocatechuic acid, isoorientin, orientin and isovitexin in bamboo leaf. Orientin has been shown to exert vaso-relaxant activity and cardioprotective effects in preclinical models.
• Isovitexin (6-C-glucosylapigenin) and Vitexin (8-C-glucosylapigenin): identified as important antioxidant and anti-inflammatory constituents.
• Tricin: BEX inhibits palmitic acid-induced overproduction of proinflammatory cytokines such as interleukin 6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), and this anti-inflammatory effect is partially mediated by flavonoids such as tricin.
• Luteolin derivatives: The most possible compounds responsible for anti-allergy activity of bamboo were 8-C-glucosyl apigenin, luteolin derivatives and chlorogenic acid. O-hexosyl-O-deoxyhexosyl tricin was the possible compound responsible for the antibacterial and melanin inhibition activity of bamboo, while apigenin derivatives might be the compounds responsible for the antioxidant activity.
• Coenzyme Q10 and myricetin: In addition to C-glycosyl flavonoids, other constituents isolated from bamboo leaf include coenzyme Q10 (CoQ10) and myricetin, which suppress atherosclerosis by preventing the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS).

3.3 Phenolic Acids

Various active compounds, such as flavones, glycosides, phenolic acids, coumarin lactones, anthraquinones and amino acids, have been isolated from bamboo leaves. Chlorogenic acid is the most consistently identified phenolic acid. Bamboo sheath (BS) was found to be particularly rich in phenolic acids.

3.4 Silica (Silicon Dioxide)

Silica (SiO₂), or its biologically active form as monosilicic acid, is the mineral constituent that defines bamboo's identity as a dietary supplement in Western markets. Bambusa bambos is the plant of choice when considering the mineral silica. It contains 10 times the silica content of both stinging nettle and horsetail. In vitro studies have shown that silicon stimulates the synthesis of type 1 collagen and osteoblastic differentiation (assessed by alkaline phosphatase and osteocalcin levels) in osteoblastic-like human cells and increases the formation of mineralization nodules in mature osteoblasts. Silica is involved in the synthesis of collagen and glycosaminoglycans, which are important components of skin, hair, and nails. It also contributes to bone mineralization.

3.5 Phytosterols

More than 200 different kinds of phytosterols have been reported in plants, among which sitosterol is the most abundant. β-Sitosterol, stigmasterol, and campesterol are the predominant sterols in bamboo shoots. 2,6-Dimethoxy-p-benzoquinone isolated from the skin of bamboo trees and two chitin-binding peptides (Pp-AMP1 and Pp-AMP2) isolated from bamboo shoots were found to have antibiotic activities. Stigmasterol and dihydrobrassicasterol isolated from the skin of bamboo shoot showed antibacterial activity.

3.6 Polysaccharides and Dietary Fibre

Dietary fiber was found to be 2.84 g/100 g fresh weight in bamboo shoot. The dietary fiber in bamboo shoots is predominantly insoluble, comprising 60–90 g/100 g dry weight of the total carbohydrate content. Polysaccharides from bamboo stems and leaves have been investigated for immune-modulating and anti-inflammatory properties in preclinical models.

3.7 Amino Acids

Bamboo shoots contain generally tyrosine, arginine, histidine, and leucine as amino acids. The protein content varies by species and developmental stage: the protein content of bamboo shoot was reported at 2.7 g/100 g fresh weight, making it a valuable plant-based protein source.

3.8 Anti-Nutritional Constituents (Cyanogenic Glycosides)

The cyanogenic glycoside present in bamboo shoots is taxiphyllin, a p-hydroxylated mandelonitrile tiglochinin which is highly unstable and thermolabile. Upon hydrolysis, taxiphyllin is degraded into glucose and hydroxybenzaldehyde cyanohydrin, which is further degraded into hydrogen cyanide (HCN) and hydroxybenzaldehyde. This compound is the primary safety-relevant constituent of bamboo shoots (see Section 7).

---

4. Mechanisms of Action

4.1 Anti-Inflammatory Mechanisms

Bamboo extract reduces interleukin 6 (IL-6) overproduction under lipotoxic conditions through inhibiting the activation of NF-κB and AP-1 pathways. These two transcription factors are master regulators of inflammatory gene expression. In cell culture research, 0.1 and 0.2 mg/mL bamboo sheath (BS) and bamboo leaf (BL) extracts reduced Interleukin-6 and Monocyte Chemoattractant Protein-1 production in human lipopolysaccharide-stimulated THP-1 macrophages, without affecting cell viability. In the Sasa albomarginata species, the extract inhibited inflammatory mediators such as LPS-induced NO, IL-6, and ROS production in mouse monocyte leukemia RAW264.7 cells. It also inhibited iNOS, IL-6, and IL-1β expressions. Moreover, it inhibited LPS-induced IL-6 expression and production in human monocyte leukemia THP-1 cells differentiated into macrophages.

4.2 Antioxidant Mechanisms

Bamboo extracts and isolated compounds exert antioxidant activity via direct radical scavenging and upregulation of endogenous antioxidant enzymes. Bamboo leaves exhibited a total phenol content (TPC) value of 73.92 mg eq gallic acid/g fresh weight and demonstrated a significant ability to scavenge radicals against ABTS·⁺, with an IC50 of 3.07 μg/mL for leaf extract and 6.78 μg/mL for sheath extract. In animal feeding studies, a significant decrease of serum triglyceride and LDL-cholesterol content was observed with bamboo leaf extract supplementation. BLE supplementation linearly improved the total antioxidant capacity and catalase activity in both serum and liver.

4.3 Silicon's Role in Collagen and Connective Tissue

Silica is involved in the synthesis of collagen and glycosaminoglycans, which are important components of skin, hair, and nails. It also contributes to bone mineralization. Silicon has been shown to be involved in the cross-linking of collagen and proteoglycans within the bone matrix in preclinical research. It is essential for collagen synthesis, providing structural integrity to skin, hair, and nails. By strengthening connective tissue and improving elasticity, silica may reduce hair shedding and promote overall hair health. When combined with biotin, silica is thought to enhance the benefits: biotin boosts keratin production, while silica supports collagen synthesis, potentially improving skin strength and elasticity.

4.4 Antidiabetic Mechanisms

Studies on Sasa borealis extract's antidiabetic effect via activation of AMP-activated protein kinase (AMPK) showed that treatment with the extract increased insulin signaling and phosphorylation of AMPK, which stimulated downstream metabolic expression. Additionally, orientin from bamboo may enhance the activity of aldose reductase and inhibit the formation of advanced glycation end products, potentially playing a role in the prevention of diabetic complications. These mechanisms have been established in cell and animal studies only; no human clinical trials specifically for antidiabetic effects of bamboo have been identified.

---

5. Scientific Evidence by Area of Application

5.1 Hair, Skin, and Nail Health

This is the area with the most direct human clinical research on bamboo-derived supplements, primarily via the bamboo silica constituent.

Clinical evidence (bamboo-derived silica): A randomized, double-blind, placebo-controlled clinical trial enrolled 105 participants, with 97 completing the 90-day study. Participants received either placebo, a botanical extract standardized for biotin (1.25 mg orally), or a botanical extract standardized for biotin combined with bamboo-derived silica (1.25 mg biotin with 21.75 mg silica orally). Efficacy was evaluated through clinical and instrumental assessments of hair fall and growth rate, skin elasticity, hydration, wrinkle reduction, and nail texture. In the post-90-day evaluation, hair fall reduced significantly (p < 0.001) in both the biotin and biotin-with-silica groups. Hair growth rate increased by 0.55 mm/day (p < 0.0001) in the biotin group and 0.57 mm/day (p < 0.0001) in the biotin with silica group. Nail roughness also reduced significantly (p < 0.0001) in both treatment groups.

Clinical evidence (choline-stabilized orthosilicic acid, ch-OSA — a bioavailable silicon form): In a study with 50 healthy volunteers aged between 40 and 65 years with clear clinical signs of facial photoaging, supplementation with ch-OSA (2 capsules containing 10 mg of ch-OSA daily) for 20 weeks was evaluated. This was reported as the first randomized, double-blind, placebo-controlled trial showing positive results in skin microtopography and anisotropy after intake of a silicon-containing supplement. At the end of the study period, there was a significant improvement in skin surface characteristics and mechanical properties. A significant improvement in the fragility of nails and hair was also observed. Another randomized study with 48 volunteers investigated the effect of ch-OSA on hair; volunteers had thin hairs and were divided into two groups (ch-OSA and placebo), with the first group receiving daily doses of 10 mg of silicon for 9 months.

Limitations: While silica is known to be important for collagen synthesis, research on bamboo extract specifically is still emerging. Some studies suggest benefits for skin elasticity and hair strength, but more robust clinical trials are needed to confirm these effects and compare them to other silicon sources. Furthermore, claims that bamboo extracts, polysaccharides, or phytoestrogens stimulate fibroblast collagen production are largely unsupported, with most evidence limited to in vitro studies that lack clinical translation. There is limited scientific evidence assessing the safety and efficacy of these combinations in controlled human studies.

5.2 Anti-Inflammatory Activity

Evidence type: Primarily preclinical (in vitro and animal). No large-scale human RCTs have been published specifically on bamboo's anti-inflammatory outcomes.

Several studies have proven that bamboo extracts and their constituents exhibit anti-inflammatory properties by blocking signaling pathways which play a key role in the production of pro-inflammatory mediators, or by inhibiting pro-inflammatory cytokines. The anti-inflammatory activities of bamboo leaf extracts specifically have been described in different cellular contexts. The antioxidant and anti-inflammatory properties of bamboo leaf and sheath by-products have been demonstrated, emphasizing their potential application in food, nutraceutical, cosmetic, and pharmaceutical sectors. Despite the growing identification of chemical compounds in bamboo, most pharmacological studies have focused on bamboo leaf flavonoids.

To ascertain whether bamboo extracts elicit any cytotoxic effects, an MTT assay was performed in human THP-1 macrophages. The exposure of cells for 24 h to bamboo sheath and bamboo leaf extracts, at concentrations of 0.1 and 0.2 mg/mL, did not affect cell viability, supporting the potential use of these extracts by the healthcare industry. The overall evidence for anti-inflammatory effects in humans is preliminary and requires well-designed clinical intervention trials.

5.3 Antioxidant Activity

Evidence type: Robust in vitro; some animal data; minimal direct human evidence.

Extracts from different parts of bamboo have different chemical compositions and different antioxidative, antibacterial and antiallergic activities, as well as effects on melanin biosynthesis. The antioxidant capacity of bamboo leaf flavonoids — particularly isoorientin, orientin, isovitexin, and apigenin derivatives — has been demonstrated across multiple assays (DPPH, ABTS, FRAP). Bamboo leaf extract supplementation linearly improved total antioxidant capacity and catalase activity in both serum and liver of broiler chickens. Glutathione peroxidase was increased in serum and liver with BLE supplementation. Malonaldehyde content in liver showed a linear and quadratic decrease with BLE supplementation. These are animal data (broiler chickens) and not directly translatable to human outcomes.

5.4 Cardiovascular and Lipid Effects

Evidence type: Preclinical (animal models and cell culture); no published human RCTs specifically for cardiovascular endpoints.

Bambusa bambos contains bioactive compounds including polyphenols, flavonoids, and polysaccharides, demonstrating antihypertensive and cardioprotective properties. Its primary active compounds, particularly bamboo leaf flavonoids, have shown significant lipid-lowering and anti-inflammatory effects in prior studies. However, a critical gap exists as these studies predominantly investigate isolated compounds or focus on single-organ effects. This approach, while informative, may not fully elucidate the plant's potential systemic cardiovascular benefits in a multifactorial, chronic disease model like atherosclerosis, where holistic effects are crucial.

When high-cholesterol mice were treated with different concentrations of bamboo leaf extract, there was a notable reduction in serum cholesterol. CoQ10 and myricetin, isolated from bamboo leaf, suppress atherosclerosis by preventing the production of ROS and reactive nitrogen species. The inflammatory chemokine MCP-1 has been a focal target: MCP-1 is an inflammatory chemokine up-regulated in obese subjects, contributing to the development of type 2 diabetes. One study investigated the inhibitory effect of an ethanol-water extract from bamboo (Phyllostachys edulis, BEX) on the blood concentration of MCP-1. C57BL/6J mice were fed a standard diet or a high-fat diet with or without BEX supplement (11 g dry mass/17,000 kJ) for 6 months. This was an animal study; human cardiovascular efficacy data are lacking.

5.5 Antidiabetic and Metabolic Effects

Evidence type: Animal and cell culture models only; no human RCTs on glycemic outcomes.

Moso bamboo leaf extract was studied in 50 diabetic rats, which illustrated a hypoglycemic effect. Sasa borealis leaf extract was substituted for meat in a food patty, which significantly lowered plasma glucose, indicating antidiabetic activity. The inhibitory effect of the leaves of Pseudosasa japonica was evaluated on high-fat diet-induced obesity and diabetes in C57BL/6J mice. Leaves of Sasa borealis, a species of bamboo, were reported to exhibit antihyperglycemic effects. However, the antidiabetic mechanism was not fully understood. Studies on Sasa borealis extract's antidiabetic effect via activation of AMPK were also conducted. These findings are restricted to animal models and cannot be extrapolated to humans.

5.6 Bone Health

Evidence type: Preclinical in vitro data for silicon's role in osteogenesis; population-level epidemiological associations for dietary silicon and bone mineral density; no clinical trials with bamboo extract specifically for bone outcomes.

In vitro studies have shown that silicon stimulates the synthesis of type 1 collagen and osteoblastic differentiation (assessed by alkaline phosphatase and osteocalcin levels) in osteoblastic-like human cells and increases the formation of mineralization nodules in mature osteoblasts. Epidemiological data (from the Framingham Offspring Cohort and similar studies) have shown a positive association between dietary silicon intake and cortical bone mineral density in men and premenopausal women, but these studies involve dietary silicon intake broadly — not bamboo extract specifically. Despite its extensive historical use, modern scientific investigation into Bamboo manna's mechanisms of action and clinical efficacy remains in the early stages. Preliminary studies suggest that the silica in Bamboo manna may play a crucial role in promoting collagen synthesis, which is vital for maintaining structural integrity.

5.7 Antimicrobial Activity

Evidence type: In vitro laboratory studies; no clinical trial data.

Several bioactive compounds such as glycosides, coumarin lactones, anthraquinones and 2,6-dimethoxy-p-benzoquinone have been isolated from bamboo leaves and shoots, among which anthraquinones and coumarins show strong anti-bacterial and bactericidal properties. 2,6-Dimethoxy-p-benzoquinone isolated from the skin of bamboo trees and two chitin-binding peptides (Pp-AMP1 and Pp-AMP2) isolated from bamboo shoots were found to have antibiotic activities. All antimicrobial evidence is in vitro; clinical relevance has not been established.

5.8 Neuroprotective and Neurobehavioural Effects

Evidence type: Animal models only.

Investigation of the protective effects of bamboo extract (BEX) on anxiety- and depression-like neurobehaviours in mice treated with a high-fat diet showed that decreased total glutathione concentration in the blood co-occurred with high-fat treatment and high anxiety level, and when supplemented in a high-fat diet, BEX had an anxiolytic effect in mice. A compound isolated from the leaves of Phyllostachys nigra was shown to protect oxidative stress-induced retinal ganglion cell death in laboratory models. No human studies on neurological endpoints are available.

5.9 Digestive Health

Bamboo shoots' high insoluble dietary fiber content is their most well-established nutritional attribute for digestive function. Due to the presence of bioactive compounds — phenols, phytosterols, and dietary fibres — bamboo plays a vital role in health promotion as well as prevention of cardiovascular, cancer and chronic diseases. The dietary fiber in bamboo shoots is predominantly insoluble, comprising 60–90 g/100 g dry weight of the total carbohydrate content. Consumption of adequate insoluble fiber is broadly established in nutrition science to support bowel regularity, but specific human intervention studies using bamboo shoots for defined digestive outcomes are limited.

5.10 Anticancer Activity

Evidence type: Preclinical only (in vitro and animal). No clinical evidence.

The anticancer property of bamboo shoots might be attributed to the presence of lignans and phytosterols. The production of carcinogens, growth of cancer cells, cell invasion, and metastasis are inhibited by phytosterol in preclinical models. Regular intake of bamboo shoots may completely scavenge the free radicals producing destructive carcinogens due to the presence of anticarcinogenic agents. These statements reflect preliminary laboratory findings and ethnobotanical observations, not clinical evidence.

---

6. Dosage Forms and Reported Dosages

The following dosages appear in peer-reviewed or clinical sources and are reported exactly as stated; they do not represent recommendations.

• Bamboo silica (from Bambusa arundinacea) + biotin combination: Treatment C in the RCT consisted of a botanical extract standardized for biotin with silica — 1.25 mg biotin with 21.75 mg silica, orally administered over 90 days.
• Choline-stabilized orthosilicic acid (ch-OSA — a bioavailable silicon form, not bamboo-specific but used as a comparator): Supplementation was held for 20 weeks, with 2 capsules containing 10 mg of ch-OSA taken daily.
• Bamboo leaf extract (BLE) in animal research: One-day-old broilers were divided into six groups; five experimental groups were supplemented with 1.0, 2.0, 3.0, 4.0, and 5.0 g BLE per kg feed in their basal diets.
• Bamboo extract (BEX, Phyllostachys edulis) in mouse study: C57BL/6J mice were fed a standard diet or a high-fat diet with or without the BEX supplement (11 g dry mass/17,000 kJ) for 6 months.
• Standardized bamboo stem/leaf extract capsules (commercial supplement forms, reported range): According to supplement ingredient databases, bamboo extract standardized to 70–75% silica is used at 300–600 mg per day, though this figure derives from commercial documentation rather than controlled clinical trials.

---

7. Safety Considerations and Interactions

7.1 Cyanogenic Glycoside Toxicity (Taxiphyllin)

This is the most significant, peer-reviewed safety concern associated with bamboo. Bamboo shoots contain cyanogenic glycosides, primarily taxiphyllin, posing toxicity risks if improperly consumed. This represents the central food safety issue around bamboo shoot consumption. The cyanogenic glycoside taxiphyllin is highly unstable and thermolabile. Upon hydrolysis, taxiphyllin is degraded into glucose and hydroxybenzaldehyde cyanohydrin, which is further degraded into hydrogen cyanide (HCN) and hydroxybenzaldehyde.

The content of hydrogen cyanide (HCN) varies depending on parts of the shoots and the bamboo species, ranging from less than 100 to nearly 1000 mg HCN per kg of fresh shoot. When the shoots are disrupted by cutting or peeling, a glycosidase enzyme in the shoots hydrolyzes the glycoside and produces HCN. Consumption of bamboo species with high levels of total cyanogenic content in Asia by many ethnic groups is significantly associated with food poisoning and occasionally Konzo (a neurological disorder). Adequate characterization of edible bamboo species with low levels of total cyanogenic content and high nutritious attributes is required for consumer safety.

Traditional and industrial processing methods, such as boiling, fermentation, and steaming, reduce taxiphyllin levels to ensure food safety. Despite their rich nutritional value, bamboo shoots contain cyanogenic glycosides such as taxiphyllin, which can release toxic hydrogen cyanide when consumed in large quantities. Under optimal conditions, lactic acid from fermentation of bamboo shoot reduces total cyanide content.

During processing, heat derivatives of the potentially toxic cyanogenic glycoside taxiphyllin are produced. The two major diarylbutenedinitrile derivatives (cis and trans isomers of 2,3-bis(4-hydroxyphenyl)but-2-enedinitrile) from boiled bamboo shoots of Bambusa vulgaris were associated with a decrease in levels of taxiphyllin. These compounds were quantified in all 16 commercial products tested, with abundance highly variable, ranging from 1 to 3 mg/g in preserved bamboo shoots and from 10 to 160 mg/mL in commercial aqueous extracts.

7.2 Other Anti-Nutritional Factors in Bamboo Shoots

Bamboo shoot is a valuable source of food but it contains antinutrients such as cyanogenic glycosides, glucosinolates, tannins, oxalates, and phytates. The most predominant antinutrient is cyanogenic glycosides. These cause increases in blood glucose and lactic acid levels and a decrease in the ATP/ADP ratio, indicating a shift from aerobic to anaerobic metabolism. Anti-nutrients such as phytate can cause vitamin and mineral deficiencies.

7.3 Arsenic Accumulation

Although arsenic is predominantly found in inorganic forms in most terrestrial plants, a significant amount of organic arsenic was found in shoots of Phyllostachys edulis despite an absence of such compounds in the soil, suggesting a possible arsenic methylation process in the shoots, especially in the core section. This indicates that bamboo may bioaccumulate arsenic from certain environments, which is a potential concern for regularly consumed shoot products.

7.4 Cytotoxicity of Leaf Extracts at Higher Concentrations

While bamboo sheath (BS) did not affect cell viability in HepG2 liver cells at tested concentrations, bamboo leaf (BL) exhibited cytotoxicity in HepG2 cells at the same concentrations in vitro. This distinction between plant parts and extract types is relevant; it underscores the importance of defining the exact botanical preparation and concentration when evaluating safety. Additional research is required to examine the mechanism of action and toxicological characteristics of various bamboo extracts for the purpose of utilizing plant biomass for human health benefits.

7.5 Safety of Leaf Flavonoid Preparations

Bamboo leaf flavonoids used as food additives — particularly in China, where they are approved for use in food processing — have been evaluated for safety and support a relatively low-toxicity profile based on regulatory review. The exposure of THP-1 macrophage cells for 24 hours to bamboo sheath and leaf extracts at concentrations of 0.1 and 0.2 mg/mL did not affect cell viability, supporting potential use by the healthcare industry.

7.6 Potential Drug and Nutrient Interactions

No pharmacokinetic drug-interaction studies for bamboo extracts in human subjects have been identified in peer-reviewed literature. Silicon/silica supplementation has not been associated with significant drug interactions in clinical studies. The high oxalate content of some bamboo species may theoretically interfere with calcium absorption in individuals predisposed to calcium oxalate kidney stones, consistent with the broader effects of high-oxalate foods. Despite the growing identification of chemical compounds in bamboo, most pharmacological studies have focused on bamboo leaf flavonoids. Further studies are needed to evaluate the activities of different bamboo by-products and to perform toxicity studies on this plant.

7.7 Reproductive and Gestational Considerations

Though scientifically not proven, some tribal communities believe bamboo shoot causes abortion in pregnant women. No clinical data are available to confirm or refute this observation. Given the presence of cyanogenic glycosides and other bioactive constituents, caution in pregnancy is warranted based on the precautionary principle until clinical data exist.

---

8. Body Systems and Health Areas Associated with Bamboo

Based on the literature reviewed, bamboo preparations have been studied or traditionally used across the following body systems:

• Integumentary system (skin, hair, nails): Most clinically investigated area; primarily via silica/silicon's role in collagen and keratin biology.
• Musculoskeletal system: Silica and bone mineral density; preclinical evidence for joint and connective tissue support.
• Cardiovascular system: Preclinical evidence for lipid-lowering, anti-inflammatory, and anti-atherosclerotic properties of bamboo leaf flavonoids.
• Immune and inflammatory system: Inhibition of NF-κB/AP-1 signaling; reduction of pro-inflammatory cytokines (IL-6, MCP-1, TNF-α) in cell and animal models.
• Metabolic and endocrine system: Antidiabetic and antihyperglycemic activity in animal models via AMPK activation and inhibition of advanced glycation end products.
• Gastrointestinal system: High insoluble fiber supporting gut motility; traditional use as carminative and mild laxative.
• Respiratory system: Traditional use (tabashir, leaf decoctions) for cough, bronchitis, and phlegm management; no clinical trial data.
• Nervous system: Neuroprotective and anxiolytic effects in animal models only.
• Ophthalmic: Preclinical evidence that compounds from bamboo leaf protect retinal ganglion cells against oxidative stress.

---

9. Summary of Evidence Quality

Bamboo species show several promising therapeutic activities including anti-cancer, anti-diabetic, cardioprotective, anti-inflammatory, antioxidant, neuroprotective, and anti-bacterial properties based on in vitro and animal research. However, the overall quality of clinical evidence for bamboo as a dietary supplement remains limited. The most substantiated human clinical evidence is for bamboo-derived silica in the context of hair, skin, and nail health, represented by a single randomized double-blind trial (Patel et al., 2025, Cureus) and several silicon (not bamboo-specific) clinical studies using ch-OSA formulations. Anti-inflammatory, antidiabetic, cardiovascular, anticancer, and neuroprotective effects have been demonstrated only in cell culture and animal models. Further studies are needed to evaluate the activities of different bamboo by-products and to perform toxicity studies on this plant. Despite its extensive historical use, modern scientific investigation into bamboo's mechanisms of action and clinical efficacy remains in the early stages.

References

• Liao et al. (2018). Biological Activities and Phytochemical Profiles of Extracts from Different Parts of Bamboo (Phyllostachys pubescens). PMC/MDPI Molecules.
• Panee J. (2015). Potential Medicinal Application and Toxicity Evaluation of Extracts from Bamboo Plants. J Med Plant Res. PMC4659479.
• Higa JK, Panee J. (2011). Supplement of bamboo extract lowers serum monocyte chemoattractant protein-1 concentration in mice fed a diet containing high level of saturated fat. PMC4659480.
• Higa JK et al. (2011). Supplement of bamboo extract lowers serum MCP-1 in mice fed high saturated fat. Br J Nutr. PMID 21736779.
• Panee J. (2008). A novel function of bamboo extract in relieving lipotoxicity. PubMed PMID 18350521.
• Patel DK et al. (2021). Bamboo a Supplement to Human Health: A Comprehensive Review on its Ethnopharmacology, Phytochemistry, and Pharmacological Activity. Natural Products Journal. Bentham Science.
• Cheng Y et al. (2024). A Review of the Nutritional Composition, Storage Challenges, Processing Technology and Widespread Use of Bamboo Shoots. PMC11592693.
• Nongdam P, Tikendra L. (2014). The Nutritional Facts of Bamboo Shoots and Their Usage as Important Traditional Foods of Northeast India. PMC5489443.
• Nongdam P, Tikendra L. (2014). Bamboo shoots as a nutritive boon for Northeast India: an overview. PMC4897250.
• Singh A et al. (2022). Quality improvement of bamboo shoots by removal of antinutrients using different processing techniques: A review. PMC8758816.
• Effects of Processing on Antinutrients, Bioactives and Functional Properties of Bamboo Shoots (Bambusa beecheyana). PMC12984204.
• Tundis R et al. (2023). Anti-Inflammatory and Antioxidant Effects of Leaves and Sheath from Bamboo (Phyllostacys edulis J. Houz). Antioxidants. PMC10294923.
• Tanaka M et al. (2022). Cellular Anti-Inflammatory and Antioxidant Activities of Bamboo Sasa albomarginata Leaf Extract and Its Constituent Coumaric Acid Methyl Ester. PMC9626218.
• Shen M et al. (2019). Effect of Bamboo Leaf Extract on Antioxidant Status and Cholesterol Metabolism in Broiler Chickens. Animals. PMC6770790.
• Rondanelli M et al. (2021). Silicon: A neglected micronutrient essential for bone health. PMC8283247.
• Patel MN, Maheshvari J, Patel N. (2025). The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Cureus. PMC12397994.
• Araújo LA et al. (2016). Use of silicon for skin and hair care: an approach of chemical forms available and efficacy. An Bras Dermatol. PMC4938278.
• Niyogi A et al. (2025). Uncovering Taxiphyllin in bamboo shoots: An analytical perspective. PubMed PMID 40179559.
• Wierzbicka I et al. (2021). Cyanogenic Derivatives as Chemical Markers for the Authentication of Commercial Products of Bamboo Shoots. PubMed PMID 34425053.
• Bamboo Manna (Vanshalochan): A Review of Silica-Rich Panacea for Health and Wellness. Biosciences Biotechnology Research Asia. (2024).
• Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration. PMC12739960.
• Multitasking bamboo leaf-derived compounds in prevention of infectious, inflammatory, atherosclerotic, metabolic, and neuropsychiatric diseases. Pharmacological Research. ScienceDirect. (2022).
• Sangeetha R et al. (2015). The Amazing Bamboo: A Review on its Medicinal and Pharmacological Potential. Indian Journal of Nutrition.